The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)
is a non profit collaborative research network that links pharmaceutical companies and researchers collaborating on clinical trials in the desire to research and develop treatments for patients with mild cognitive impairment and dementia.
We are equipped to undertake any new clinical trial in dementia or Mild Cognitive Impairment in phase I, II, III or IV.
- expert scientific review of clinical trial protocol
- centrally negotiated budget for all C5R research sites